Analyst Ratings for Tonix Pharma (TNXP)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/28/2024 | Dawson James | Jason H. Kolbert | New Coverage | Buy (N/A) |
3.00 (N/A) |
0.37 (13.45) |
3535.14% | Details |
| 4/18/2022 | Noble Capital » Updated 3/25/2025 |
Robert LeBoyer | New Coverage | Outperform (N/A) |
70.00 (N/A) |
0.19 (13.45) |
6978.95% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
